Sudden unexpected cardiac arrest is due in most cases to ventricular fibrillation or rapid ventricular tachycardia.1,2 More than half the patients suffering from life-threatening ventricular tachyarrhythmias have advanced coronary artery disease, and most have a history of remote myocardial infarction. Less frequent causes are cardiomyopathies, valvular heart disease, congenital heart disease, Wolff-ParkinsonWhite syndrome, and long QT syndrome. [3] [4] [5] [6] In a number of patients with ventricular tachyarrhythmias, no underlying structural heart disease can be established despite extensive evaluation. Such patients are described as having primary electrical disease or idiopathic ventricular tachyarrhythmia.7 Prognosis in these patients has been described as excellent by many authors, although rare cases of sudden death have been reported. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] There appears to be agreement that only symptomatic patients with recurrent arrhythmia should be treated, and no particular efforts have been directed toward identification of high-risk subgroups or prevention of sudden cardiac death. It is noteworthy that many of these reports deal with patients with idiopathic ventricular tachycardia without hemodynamic deterioration.
We raised the question of whether prognosis also is favorable for the subgroup of patients with primary electrical disease who have survived an episode of ventricular fibrillation. Methods 
Patients
We prospectively evaluated the outcome in 19 consecutive patients with primary electrical disease who had survived an episode of documented ventricular fibrillation (index episode) and were referred to the Cardiac Arrhythmia Unit of the Heart-Lung Institute, Utrecht, between October 1985 and June 1992 . No patient was on antiarrhythmic drugs at the time of circulatory collapse.
Diagnostic Evaluation
Diagnosis. Primary electrical disease is a diagnosis by exclusion. In our series, this diagnosis was made only when thorough clinical evaluation did not provide evidence for structural heart disease or other known causes of ventricular arrhythmia. All patients were evaluated according to a predefined protocol (baseline evaluation). In addition to the patient's history, routine physical examination, 12-lead ECG, 24-hour two-channel Holter monitoring, exercise testing (Bruce protocol) and Valsalva maneuver,23 laboratory tests, and chest roentgenograms, evaluation included echocardiography with wall motion analysis and Doppler screening, cardiac catheterization with cineangiography of both the left and right ventricle, coronary angiography, nuclear scintigraphic assessment of left ventricular ejection fraction, and multiple right ventricular endomyocardial biopsies. In patients undergoing defibrillator implantation, additional transmural biopsies were taken from the right and left ventricular walls. Acute myocardial infarction was excluded. Identifiable and correctable causes of ventricular arrhythmia such as acute ischemia, metabolic or electrolyte disturbances, and drug toxicity were absent. Preexcitation patterns and long QT interval, either persistent or transient, also were excluded. Measurement of corrected QT intervals was performed according to Bazett's formula. 24 During hospitalization, all patients were kept in the telemetry monitoring area.
Electrophysiological study. Baseline electrophysiological study was performed off antiarrhythmic drugs in all patients and included an analysis of the sinus node recovery time and atrioventricular conduction parameters. 25 Programmed electrical stimulation in the high right atrium was performed with the single extrastimulus technique after a basic drive cycle length of 600 or 500 milliseconds. Inducibility of ventricular tachyarrhythmias was tested at the right ventricular apex and, in case of noninducibility, also at the right ventricular outflow tract. 26 Programmed electrical stimulation was carried out with 2-millisecond pulse width at twice-diastolic threshold current, using up to three extrastimuli during sinus rhythm and ventricular pacing at 600-and 430-millisecond basic drive cycle lengths.2728 In addition, a long-short sequence of extrastimuli was used as described by Denker stimulation. Appropriate AICD shock is documented shock delivery preceded by a syncopal attack, sudden and transient dizziness (presyncope), or sudden onset of palpitations. Shocks under other conditions are defined as undetermined. Last, major arrhythmic event is documented ventricular fibrillation or sustained rapid ventricular tachycardia or sudden death without evidence of a nonarrhythmic cause and appropriate AICD shock.
Data Analysis
A Kaplan-Meier curve was used for graphic display of the occurrence of major arrhythmic events during follow-up. 32 Analysis of potentially predictive markers of outcome included age and sex of the patients, events before index episode, abnormal 12-lead ECG, ventricular tachyarrhythmia on Holter recording or induced by exercise, and inducibility by programmed electrical stimulation. The relationship of these characteristics with the occurrence of major arrhythmic events during follow-up was statistically analyzed using Fisher's exact two-tailed test. This relationship was also expressed as hazard ratios, which may be interpreted as relative risks. The precision of the hazard ratio estimates was described by means of 95% confidence intervals obtained from the Cox proportional-hazards model.33
Results

Patients
Patient characteristics are summarized in Table 1 . Information on baseline ventricular tachyarrhythmia detected during Holter recording, exercise testing, or induced at baseline programmed electrical stimulation is shown in Table 2 .
Fifteen men and four women were included in the study (Fig 1) . This Table 1 ).
Holter monitoring. Episodes of ventricular tachyarrhythmia were recorded in 5 patients (26%). Four had ventricular tachycardia of three to nine complexes, and the other had transient ventricular fibrillation (see Table 2 and Fig 1) . In 11. Rapid ventricular tachyarrhythmias were inducible in 10 patients (53%; Table 2 ). In 2 patients, rapid monomorphic ventricular tachycardia episodes were induced with a left bundle branch block pattern in lead V, of the surface ECG. In patient 9, tachycardia episodes were sustained, and in patient 12, episodes were nonsustained (11 complexes). In 8 patients (42%), either nonsustained rapid polymorphic ventricular tachycardia (patients 4 and 10; 10 to 22 complexes) or ventricular fibrillation (6 patients) was induced. Ventricular fibrillation was induced with only a single extrastimulus or with two extrastimuli in 3 of these patients (patients 1, 5, and 13). induction. Inducibility in all 10 patients was obtained without administration of isoproterenol. Nine patients (47%) showed noninducibility. In all of these 9 patients, programmed electrical stimulation included burst stimulation and a repeated study during isoproterenol infusion.
Treatment
Parameters to evaluate antiarrhythmic drug efficacy were present in 11 patients (58%), all of whom were given antiarrhythmic drugs as first-choice therapy. Treatment was guided by Holter monitoring and exercise testing in patients 2 and 17. In the other 9 of these 11 patients, drug efficacy was evaluated by repeated programmed electrical stimulation because of absence of assessable ventricular tachyarrhythmia episodes with Holter recording and exercise testing at baseline.
Pharmacological therapy was discontinued in patients 10 and 12 after three drug trials had failed to suppress inducibility. Nine patients were discharged on antiarrhythmic drugs.
An AICD was implanted in the other 10 patients -in 8 patients as first-choice therapy because of absence of parameters to evaluate antiarrhythmic drug therapy, including noninducibility at baseline programmed electrical stimulation, and in patients 10 and 12 after drug failure. Although 2 patients had inducible monomorphic ventricular tachycardia, ablative therapy was not carried out because of adequate drug response in patient 9 and technical reasons in patient 12.
Information on antiarrhythmic treatment at discharge is included in Table 2 .
Follow-up Duration of follow-up ranged from 5 to 85 months (mean, 43 months; median, 41 months). Major arrhythmic events occurred in 7 patients (37%; Table 2 and Fig  2) . Four of these 7 patients had shown noninducibility at baseline programmed electrical stimulation. Patient 2 died suddenly (witnessed) out-of-hospital after having been on quinidine treatment for 36 months. He died within minutes after onset of dizziness. Because ventricular fibrillation was induced at baseline programmed electrical stimulation with three extrastimuli, the response had been considered nonspecific. Treatment with quinidine had subsequently been considered effective based on complete suppression of nonsustained ventricular tachycardia and frequent early premature ventricular complexes on both Holter recording and exercise testing. Patient 1, who had been on flecainide for 32 months, was successfully resuscitated after recurrent ventricular fibrillation and subsequently underwent AICD implantation. Shocks were associated with termination of episodes of either presyncope or syncope in 5 AICD patients. In all 5 patients, rate cutoff of the AICD was programmed at 200. Three of these 5 patients had recurrent episodes of (pre)syncope followed by shocks. In 1 of these patients (patient 7), Holter recording showed appropriate shock termination of ventricular fibrillation deteriorated from polymorphic ventricular tachycardia (Fig 3) . No patient was on antiarrhythmic drugs after AICD implantation. Undetermined shocks did not occur in any patient.
Noninvasive follow-up examinations failed to reveal development of structural heart disease in any patient. Patient 10 died from a noncardiac cause after 30 months of follow-up.
Markers predictive of outcome could not be identified, although a history of ventricular fibrillation or (pre)syncope before the index episode appeared to indicate an increased risk (Fisher's exact test: onesided P=.04; two-sided P=.06; Cox proportional-hazards model: hazard ratio, 6.1; 95% confidence interval, 0.7 to 5.1).
Discussion
The major finding of the present study is the high recurrence rate of life-threatening events during longterm follow-up in patients with primary electrical disease who presented with ventricular fibrillation. Also striking was the low mean age of the patients (33 years). The 19 patients with idiopathic ventricular fibrillation described in this study constitute 8% of all survivors of sudden cardiac arrest due to a ventricular tachyarrhythmia who were admitted to our department between October 1985 and June 1992. Because our institute is a referral center, this percentage is unlikely to reflect the actual prevalence of the disease. Nevertheless, the data may indicate that idiopathic ventricular tachyarrhythmia is not an extremely rare cause of sudden cardiac death. Estimates in the literature vary from 1% to 14% of patients less than 40 years old who have survived an episode of sudden unexpected cardiac arrest due to ventricular tachyarrhythmia. 2, 34 Because primary electrical disease is a diagnosis by exclusion, considerable efforts have been made to establish or rule out underlying structural heart disease. Apart from mostly minor and nonspecific abnormalities in the resting 12-lead ECG, none of the tests mentioned in "Methods" yielded abnormal results. In 4 patients with borderline low serum potassium on admission, values were normal within 1 day. We have attributed these borderline low potassium levels to the known (lowering) effect of acute major stress (resuscitation). Serum magnesium was not analyzed in one patient on admission. Measurement at a later stage was normal. One patient had borderline low serum magnesium on admission that was normal within 1 day. All patients showed normal QT intervals, and none of these patients suffered from malnutrition; gastrointestinal, renal, or endocrine disorders; or alcoholism. Based on these factors, we concluded that neither hypokalemia nor hypomagnesemia was of etiological significance in these patients. Coronary angiography did not reveal any abnormality, and ventricular wall motion analysis was within normal limits in all patients. Also of note is the absence of demonstrable signs of structural cardiac pathology during follow-up. It therefore appears unlikely that the ventricular tachyarrhythmia was the first manifestation of an underlying but latent structural abnormality.
Previous The present study encompasses a relatively large group of consecutive patients with primary electrical disease and documented ventricular fibrillation who were selected meticulously and followed prospectively at a single center. All patients followed the same diagnostic and therapeutic approaches with follow-up evaluation by two of the authors. No patient was lost to follow-up. The 37% incidence of major arrhythmic events during 43 months (range, 5 to 85 months) of follow-up is striking. Events were life threatening in at least 3 of the 7 patients. Of the 9 patients discharged with antiarrhythmic drugs, 1 died suddenly and another was successfully resuscitated out-of-hospital for the second time. The interval between index episode and recurrence of cardiac arrest was 32 and 36 months, respectively, making a proarrhythmic effect less likely. The third patient with a life-threatening event had an AICD. Holter monitoring documented polymorphic ventricular tachycardia deteriorating into ventricular fibrillation terminated by shock delivery (see Fig 3) . 34 The defibrillators implanted were incapable of recording the ECG events leading to a discharge. AICD shock delivery might have been triggered by a nonfatal arrhythmia (eg, a supraventricular tachyarrhythmia). However, only 1 patient had chronic atrial fibrillation with maximum ventricular rate during exercise below documented in any of the AICD patients, and none of them had inducibility of these arrhythmias during programmed electrical stimulation. Theoretically, it also is possible that a ventricular tachyarrhythmia did trigger the defibrillator but ended spontaneously before its discharge. It appears that such uncertainties will be settled by the new generations of defibrillators with event-recording facilities. However, even with episodes that were truly terminated by a shock, uncertainty remains as to whether the arrhythmia would not have ended spontaneously at a later stage without leading to a fatal event.
Depression of baroreflex sensitivity and reduction of heart rate variability are known to be associated with an increased incidence of arrhythmic events, features mainly studied in postinfarction patients.51-53 These features were not studied in our patients. Also not studied was the presence of late potentials. Mehta and Camm54 described a low prevalence of late potentials in patients with idiopathic ventricular tachycardia.
Conclusions
Patients with primary electrical disease who present with ventricular fibrillation are at high risk of recurrence of a life-threatening arrhythmic event. Further markers to identify those at highest risk and evaluation of the most appropriate therapeutic measures clearly are needed. However, much better understanding of the mechanism of arrhythmogenesis in these patients may be required for optimum therapeutic strategy. Some of these problems will be studied by the Unexplained Cardiac Arrest Registry of Europe (U-CARE), which has just been initiated by the European Society of Cardiology. Awaiting further characterization, intensive therapy, including early implantation of a defibrillator with ECG monitoring function, is highly recommendable in all patients with primary electrical disease who have survived an episode of ventricular fibrillation.
